🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chronic Obstructive Pulmonary Disease Exacerbation

Study of Hospitalised Patients With Acute Respiratory Conditions NCT05095090n/a1 site📍 Leicester University of Leicester Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project NCT06235502NA1 site📍 Aalborg Aalborg University Hospital · Tests: Home-based cycle-exercise for COPD patients, Standard of Care The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry NCT07612878n/a7 sites📍 Indianapolis📍 Lawrence📍 Durham Sanofi · Tests: Cohort 1: Dupilumab, Cohort 2: usual care only High-intensity Resistance Training in Post-exacerbation COPD NCT07302425NA1 site📍 Lumezzane Istituti Clinici Scientifici Maugeri SpA · Tests: HIRT, HIET Multidisciplinary Management of Severe COPD NCT04860375NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Multidisciplinary patient care, Standard care The CATALINA Study NCT05008081n/a22 sites📍 Linz📍 Vienna📍 Brussels Wim Janssens This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization NCT07587658Phase 41 site📍 Mullica Hill Regeneron Pharmaceuticals · Tests: dupilumab, Placebo Interoception and Symptom Perception in Acute COPD Exacerbation NCT07719231n/a1 site📍 Istanbul Saglik Bilimleri Universitesi · Tests: No Intervention: Observational Cohort Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS) NCT05958563NA15 sites📍 Angers📍 Bordeaux📍 Brest University Hospital, Angers · Tests: continuous positive airway pressure treatment CHARM-COPD Program of Care NCT06253013NA1 site📍 Toronto University Health Network, Toronto · Tests: Hyfe Smartwatch, FitBit Versa 2, Home Spirometer, Audio recording A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD NCT07344285NA1 site📍 Shatin Chinese University of Hong Kong · Tests: Intervention Group, Usual Care Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation NCT07072039NA1 site📍 Worcester University of Massachusetts, Worcester · Tests: Paramedic Evaluation for acute COPD Exacerbation, Usual Care Chronic Airway Disease and Multimorbidity Cohort NCT06798077n/a9 sites📍 Beijing📍 Guangzhou📍 Zhengzhou China-Japan Friendship Hospital Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe). NCT06724315n/a1 site📍 São Paulo Hospital Israelita Albert Einstein High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease NCT03033251NA1 site📍 Toronto Unity Health Toronto · Tests: Non Invasive Ventilation, High Flow Oxygen Cannula 50, High Flow Oxygen Cannula 30 Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations NCT05704881n/a2 sites📍 Grenoble📍 Lyon University Hospital, Grenoble · Tests: End-Tidal CO2 measurement during COPD exacerbation Effect of IMT in Patients After Acute Exacerbations of COPD NCT07213128NA12 sites📍 Aalst📍 Anderlecht📍 Brussels KU Leuven · Tests: Training High Flow Nasal Oxygen for Exacerbation COPD NCT06084117NA4 sites📍 Delft📍 Rotterdam📍 Rotterdam Franciscus Gasthuis · Tests: HFNO, NIV Non-contact Proactive Remote Monitoring of COPD Exacerbations NCT05598983n/a1 site📍 London Life Detection Technologies Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa NCT04427826Phase 1, Phase 21 site📍 Grenoble University Hospital, Grenoble · Tests: Morphine hydrochloride Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets NCT07112235n/a1 site📍 London Imperial College London · Tests: Rhinovirus-A16 COPD Flare-Up Clinic After Severe Exacerbations NCT07629869NA1 site📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: Follow-up in a flare-up clinic Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients NCT03890224NA1 site📍 Paris Clinact · Tests: home ventilators Home High Flow Oxygen to Reduce Acute Exacerbation of COPD NCT05196698NA1 site📍 Rouen University Hospital, Rouen · Tests: High Flow Oxygen Therapy, Long-term oxygen therapy Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy NCT07030881NA9 sites📍 Hefei📍 Harbin📍 Hefei First Affiliated Hospital of Ningbo University · Tests: pMDI Triple Inhaler and Spacer, pMDI Triple Inhaler Only Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease NCT05703919Phase 41 site📍 Aarhus N Central Denmark Region · Tests: Titrated Oxygen, Standard Oxygen Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients NCT06691399NA1 site📍 Asyut Assiut University · Tests: Oral care Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting NCT05012033n/a1 site📍 London Imperial College London · Tests: No intervention - prednisolone is taken as part if routine clinical care. Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease NCT06198309n/a1 site📍 Beijing Li An Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models NCT06802003n/a1 site📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: Biometric wearable and handheld devices
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy